Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

NSE/ZIMLAB stock hub

NSE/ZIMLAB has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/ZIMLABis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

5.5B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/ZIMLAB

In the news

Latest news · NSE/ZIMLAB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 24.9P50 32.4P75 45.7

Trailing P/E79

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC3

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/ZIMLAB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

173

Groups with data

Currency

INR

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	577
Employees Change	21%
Employees Change Percent	3.78
Enterprise value	INR 6.7B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	INE518E01015
Last refreshed	2026-05-10
Market cap	INR 5.5B
Price	INR 103
Price currency	INR
Rev Per Employee	6,550,469.67x
Sector	Healthcare
Sic	2834
Symbol	nse/ZIMLAB
Website	https://www.zimlab.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.27%
EV Earnings	95.93x
EV/EBIT	36.79x
EV/EBITDA	17.21x
EV/Sales	1.77x
P/B ratio	2.19x
P/E ratio	78.99x
P/S ratio	1.46x
PE Ratio10 Y	27.13x
PE Ratio3 Y	35.5x
PE Ratio5 Y	31.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	4.82%
EBITDA Margin	9.1%
Gross margin	53.84%
Gross Profit	INR 2B
Gross Profit Growth	0.56%
Gross Profit Growth Q	9.05%
Gross Profit Growth3 Y	1.92%
Gross Profit Growth5 Y	7.55%
Net Income	INR 69.8M
Net Income Growth	-54.56%
Net Income Growth Q	9.92%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-33.95%
Net Income Growth5 Y	-2.84%
Pretax Margin	3.01%
Profit Margin	1.85%
Profit Per Employee	INR 121,021
Profitable Years	10
Roa5y	4.64
Roe5y	7.82
ROIC	3.02
Roic5y	7.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	19.8%
Cagr3y	9.44%
EPS Growth	-54.42
EPS Growth Q	9.76
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-33.96
EPS Growth5 Y	-2.71
Revenue Growth	-2.65x
Revenue Growth Q	12.8x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.73x
Revenue Growth5 Y	4.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 46.3M
Debt	INR 1.2B
Debt EBITDA	INR 3.16
Debt Equity	INR 0.49
Equity	INR 2.5B
Interest Coverage	1.67
Net Cash	INR -1.2B
Net Cash By Market Cap	INR -21.45
Net Debt EBITDA	INR 3.44
Net Debt Equity	INR 0.47
Tangible Book Value	INR 2.2B
Tangible Book Value Per Share	INR 45.63
WACC	8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	19.79%
200-day SMA	76.03
3Y total return	31.07%
50-day SMA	74.08
50-day SMA vs 200-day SMA	50under200
All Time High	152.7
All Time High Change	-32.87%
All Time High Date	2023-08-04
All Time Low	59.31
All Time Low Change	72.82%
All Time Low Date	2026-03-30
ATR	5.54
Beta	0.79
Ch YTD	42.07
High	109.5
High52	127
High52 Date	2025-07-18
High52ch	-19.29%
Low	96.1
Low52	59.31
Low52 Date	2026-03-30
Low52ch	72.82%
Ma50ch	38.37%
Price vs 200-day SMA	34.82%
RSI	81.94
RSI Monthly	55.15
RSI Weekly	72.51
Sharpe ratio	0.53x
Sortino ratio	0.93
Total Return	0.31%
Tr YTD	42.07
Tr1m	49.29%
Tr1w	8.86%
Tr3m	43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 182.1M
Operating Income Growth	-30.84
Operating Income Growth Q	16.35
Operating Income Growth3 Y	-19.31
Operating Income Growth5 Y	-5.57
Operating margin	4.82

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	19,416,684%
Shares Insiders	54.05%
Shares Qo Q	3.57%
Shares Yo Y	-0.31%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	111,898.1x
Bv Per Share	53.27
Ch1m	49.29
Ch1w	8.86
Ch1y	19.79
Ch3m	43
Ch3y	31.07
Ch6m	44.31
Change	8.25%
Change From Open	4.06
Close	94.69
Days Gap	4.02
Depreciation Amortization	161,749,500
Dollar Volume	63,872,362.5
Earnings Date	2026-05-22
EBIT	INR 182.1M
EBITDA	INR 343.8M
EPS	INR 1.43
F Score	2
Fiscal Year End	March
Founded	1,984
Graham Number	36.92917
Graham Upside	-63.97
Income Tax	INR 44M
Is Primary Listing	0
Last Earnings Date	2026-02-11
Last Report Date	2025-12-31
Last Split Date	2022-12-22
Last Split Type	Forward
Lynch Fair Value	INR 6.49
Lynch Upside	-93.67
Ma150	72.72
Ma150ch	40.96%
Ma20	84.63
Ma20ch	21.11%
Next Earnings Date	2026-05-22
Open	98.5
Position In Range	47.76
Price Date	2026-05-08
Price EBITDA	INR 16.04
Ptbv Ratio	2.56
Relative Volume	7.39x
Revenue	3,779,621,000x
Tax By Revenue	1.16x
Tax Rate	38.64%
Tr6m	44.31%
Volume	623,145

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/ZIMLAB pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/ZIMLAB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/ZIMLAB?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+54.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.3%

Negative means the company is buying back shares.

Technical

NSE/ZIMLAB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

81.9

Above 70: short-term overbought

Price vs 200-day MA

+34.8%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/ZIMLAB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/ZIMLAB stock rating?

nse/ZIMLAB is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/ZIMLAB analysis?

The full report lives at /stocks/nse/ZIMLAB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/ZIMLAB?

The latest report frames nse/ZIMLAB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/ZIMLAB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.